Researchers have invented a promising new vaccine for malaria — with properties akin to the novel RNA-based vaccine for COVID-19
Making a vaccine for malaria is challenging because its associated parasite, Plasmodium, contains a protein that inhibits production of memory T-cells, which protect against previously encountered pathogens. If the body can’t generate these cells, a vaccine is ineffective. But scientists recently tried a new approach using an RNA-based platform.
Their design circumvented the sneaky protein, allowed the body to produce the needed T-cells and completely immunized against malaria.
“It’s probably the highest level of protection that has been seen in a mouse model,” said Richard Bucala, co-inventor of the new vaccine and a physician and professor at Yale School of Medicine.
Read More at Academic Times
Read the rest at Academic Times